Patent Assignment
Reel/Frame 042704/0254
Assignment of Assignor's Interest
Recorded: 2017-06-06
Pages: 6
Assignor
ADAMAS PHARMACEUTICALS, INC.
Executed: 2017-06-05
Assignee
ADAMAS PHARMA, LLC
1900 POWELL STREET, SUITE 750, EMERYVILLE, CALIFORNIA, 94608
Covered Properties
(45)
Method and Composition for Administering an Nmda Receptor Antagonist to a Subject
Composition and Method for Treating Neurological Disease
Methods and Compositions for the Treatment of Cns-Related Conditions
Method and Composition for Administering an Nmda Receptor Antagonist to a Subject
Methods and Compositions for the Treatment of Cns-Related Conditions
Methods and Compositions for the Treatment of Cns-Related Conditions
Method and Composition for Administering an Nmda Receptor Antagonist to a Subject
Method of Administering Amantadine Prior to a Sleep Period
Method and Composition for Administering an NMDA Receptor Antagonist to a Subject
Composition for Administering an Nmda Receptor Antagonist to a Subject
Method for Administering an Nmda Receptor Antagonist to a Subject
Compositions for the Treatment of Cns-Related Conditions
Methods for the Treatment of Cns-Related Conditions
Compositions for the Treatment of CNS-Related Conditions
Method for Administering an Nmda Receptor Antagonist to a Subject
Composition and Method for Treating Neurological Disease
Methods of Administering Amantadine
Composition and Method for Treating Neurological Disease
Composition and Method for Treating Neurological Disease
Composition and Method for Treating Neurological Disease
Composition and Method for Treating Neurological Disease
Composition and Method for Treating Neurological Disease
Composition and Method for Treating Neurological Disease
Composition and Method for Treating Neurological Disease
Composition and Method for Treating Neurological Disease
Composition and Method for Treating Neurological Disease
Application:
14/856,398 →
Publication:
US 2016/0256413
Composition and Method for Treating Neurological Disease
Application:
14/856,406 →
Publication:
US 2016/0263052
Amantadine Compositions and Methods of Use
Application:
14/863,035 →
Publication:
US 2016/0151307
Methods of Administering Amantadine Compositions
Application:
14/931,546 →
Publication:
US 2016/0228388
Composition for Administering an NMDA Receptor Antagonist to a Subject
Application:
15/089,062 →
Publication:
US 2017/0056340
Compositions for the Treatment of Cns-Related Conditions
Application:
15/090,400 →
Publication:
US 2016/0250149
Compositions for the Treatment of Cns-Related Conditions
Application:
15/142,133 →
Publication:
US 2016/0243094
Compositions for the Treatment of Cns-Related Conditions
Application:
15/142,253 →
Publication:
US 2016/0243095
Compositions for the Treatment of Cns-Related Conditions
Application:
15/142,492 →
Publication:
US 2016/0250161
Compositions for the Treatment of Cns-Related Conditions
Application:
15/142,519 →
Publication:
US 2016/0243058
Composition for Administering an NMDA Receptor Antagonist to a Subject
Application:
15/351,802 →
Publication:
US 2017/0281565
Method of administering amantadine prior to a sleep period
Method of administering amantadine prior to a sleep period
Amantadine Compositions and Methods of Use
Application:
15/428,920 →
Publication:
US 2017/0151185
Amantadine Compositions and Methods of Use
Application:
15/428,946 →
Publication:
US 2017/0151186
Method of administering amantadine prior to a sleep period
Composition and Method for Treating Neurological Disease
Application:
15/429,053 →
Publication:
US 2017/0151188
Composition and Method for Treating Neurological Disease
Application:
15/429,057 →
Publication:
US 2017/0151189
Method of administering amantadine prior to a sleep period
Compositions for the Treatment of Cns-Related Conditions
Application:
15/460,787 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 7, 2006
From: WENT, GREGORY T.; FULTZ, TIMOTHY; PORTER, SETH; MEYERSON, LAURENCE R.
To: NEUROMOLECULAR PHARMACEUTICALS, INC.
Reel/Frame 017648/0618 →
Assignment of Assignor's Interest
Jun 21, 2006
From: WENT, GREGORY T.; FULTZ, TIMOTHY J.; PORTER, SETH; MEYERSON, LAURENCE R.
To: NEUROMOLECULAR PHARMACEUTICALS, INC.
Reel/Frame 018029/0559 →
Assignment of Assignor's Interest
Jul 5, 2006
From: WENT, GREGORY T.; FULTZ, TIMOTHY J.
To: NEUROMOLECULAR PHARMACEUTICALS, INC.
Reel/Frame 018079/0752 →
Change of Name
Sep 18, 2007
From: NEUROMOLECULAR PHARMACEUTICALS, INC.
To: ADAMAS PHARMACEUTICALS, INC.
Reel/Frame 019842/0670 →
Change of Name
Oct 2, 2007
From: NEUROMOLECULAR PHARMACEUTICALS, INC
To: ADAMAS PHARMACEUTICALS, INC
Reel/Frame 019959/0266 →
Assignment of Assignor's Interest
Apr 19, 2011
From: WENT, GREGORY T.; SATHYAN, GAYATRI; VERMANI, KAVITA; GANAPATI, GANGADHARA
To: ADAMAS PHARMACEUTICALS, INC.
Reel/Frame 026152/0020 →
Change of Name
Jan 23, 2012
From: NEUROMOLECULAR PHARMACEUTICALS, INC.
To: ADAMAS PHARMACEUTICALS, INC.
Reel/Frame 027576/0495 →
Assignment of Assignor's Interest
Jan 23, 2012
From: WENT, GREGORY T.; FULTZ, TIMOTHY J.
To: NEUROMOLECULAR PHARMACEUTICALS, INC.
Reel/Frame 027575/0071 →
Change of Name
Jan 23, 2012
From: NEUROMOLECULAR PHARMACEUTICALS, INC.
To: ADAMAS PHARMACEUTICALS, INC.
Reel/Frame 027576/0366 →
Assignment of Assignor's Interest
Jan 23, 2012
From: WENT, GREGORY T.; FULTZ, TIMOTHY J.; PORTER, SETH; MEYERSON, LAURENCE R.
To: NEUROMOLECULAR, INC.
Reel/Frame 027576/0046 →
Assignment of Assignor's Interest
Jan 23, 2012
From: WENT, GREGORY T.; FULTZ, TIMOTHY J.; PORTER, SETH; MEYERSON, LAURENCE R.
To: NEUROMOLECULAR, INC.
Reel/Frame 027575/0880 →
Change of Name
Jan 23, 2012
From: NEUROMOLECULAR PHARMACEUTICALS, INC.
To: ADAMAS PHARMACEUTICALS, INC.
Reel/Frame 027576/0543 →
Assignment of Assignor's Interest
Jan 23, 2012
From: WENT, GREGORY T.; FULTZ, TIMOTHY J.
To: NEUROMOLECULAR PHARMACEUTICALS, INC.
Reel/Frame 027575/0346 →
Change of Name
Jan 23, 2012
From: NEUROMOLECULAR PHARMACEUTICALS, INC.
To: ADAMAS PHARMACEUTICALS, INC.
Reel/Frame 027576/0391 →
Assignment of Assignor's Interest
Jan 26, 2012
From: MEYERSON, LAURENCE R.
To: ADAMAS PHARMACEUTICALS, INC.
Reel/Frame 027599/0789 →
Assignment of Assignor's Interest
Jan 26, 2012
From: MEYERSON, LAURENCE R.
To: ADAMAS PHARMACEUTICALS, INC.
Reel/Frame 027599/0891 →
Assignment of Assignor's Interest
Jan 26, 2012
From: MEYERSON, LAURENCE R.
To: ADAMAS PHARMACEUTICALS, INC.
Reel/Frame 027599/0839 →
Assignment of Assignor's Interest
Jul 17, 2012
From: WENT, GREGORY T.; MEYERSON, LAURENCE R.; FULTZ, TIMOTHY J.
To: ADAMAS PHARMACEUTICALS, INC.
Reel/Frame 028569/0204 →
Assignment of Assignor's Interest
Jul 17, 2012
From: WENT, GREGORY T.; MEYERSON, LAURENCE R.; FULTZ, TIMOTHY J.
To: ADAMAS PHARMACEUTICALS, INC.
Reel/Frame 028568/0966 →
Assignment of Assignor's Interest
Jul 17, 2012
From: WENT, GREGORY T.; MEYERSON, LAURENCE R.; FULTZ, TIMOTHY J.
To: ADAMAS PHARMACEUTICALS, INC.
Reel/Frame 028569/0276 →
Assignment of Assignor's Interest
Jul 17, 2012
From: WENT, GREGORY T.; MEYERSON, LAURENCE R.; FULTZ, TIMOTHY J.
To: ADAMAS PHARMACEUTICALS, INC.
Reel/Frame 028569/0354 →
Assignment of Assignor's Interest
Jul 17, 2012
From: WENT, GREGORY T.; FULTZ, TIMOTHY J.; PORTER, SETH; MEYERSON, LAURENCE R.
To: NEUROMOLECULAR, INC.
Reel/Frame 028569/0935 →
Change of Name
Jul 17, 2012
From: NEUROMOLECULAR PHARMACEUTICALS, INC.
To: ADAMAS PHARMACEUTICALS, INC.
Reel/Frame 028573/0766 →
Change of Name
Jan 29, 2013
From: NEUROMOLECULAR PHARMACEUTICALS, INC.
To: ADAMAS PHARMACEUTICALS, INC.
Reel/Frame 029717/0654 →
Assignment of Assignor's Interest
Feb 12, 2013
From: WENT, GREGORY T.; FULTZ, TIMOTHY J.; MEYERSON, LAURENCE R.
To: ADAMAS PHARMACEUTICALS, INC.
Reel/Frame 029799/0395 →